Mechanistic insights into xanthomicrol as the active anti-HCC ingredient of Phytolacca acinosa Roxb.: a network pharmacology analysis and transcriptomics integrated experimental verification DOI

Jiayao Liu,

Yang Zhou,

Pincheng Zhou

et al.

Journal of Ethnopharmacology, Journal Year: 2024, Volume and Issue: 333, P. 118467 - 118467

Published: Oct. 1, 2024

Language: Английский

Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds DOI

Hui Li Ang,

Chakrabhavi Dhananjaya Mohan, Muthu K. Shanmugam

et al.

Medicinal Research Reviews, Journal Year: 2023, Volume and Issue: 43(4), P. 1141 - 1200

Published: March 17, 2023

Abstract Epithelial‐mesenchymal transition (EMT) is a complex process with primordial role in cellular transformation whereby an epithelial cell transforms and acquires mesenchymal phenotype. This plays pivotal tumor progression self‐renewal, exacerbates resistance to apoptosis chemotherapy. EMT can be initiated promoted by deregulated oncogenic signaling pathways, hypoxia, cells the microenvironment, resulting loss‐of‐epithelial polarity, cell–cell adhesion, enhanced invasive/migratory properties. Numerous transcriptional regulators, such as Snail, Slug, Twist, ZEB1/ZEB2 induce through downregulation of markers gain‐of‐expression markers. Additionally, cascades Wnt/β‐catenin, Notch, Sonic hedgehog, nuclear factor kappa B, receptor tyrosine kinases, PI3K/AKT/mTOR, Hippo, transforming growth factor‐β pathways regulate whereas they are often cancers leading aberrant EMT. Furthermore, noncoding RNAs, tumor‐derived exosomes, epigenetic alterations also involved modulation Therefore, regulation vital strategy control aggressive metastatic characteristics cells. Despite vast amount preclinical data on cancer progression, there lack clinical translation at therapeutic level. In this review, we have discussed thoroughly aforementioned transcription factors, RNAs (microRNAs, long RNA, circular RNA), modifications, exosomes cancers. We emphasized contribution drug possible interventions using plant‐derived natural products, their semi‐synthetic derivatives, nano‐formulations that described promising blockers.

Language: Английский

Citations

118

Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment DOI Creative Commons

Ziting Zhang,

You Ji,

Nan Hu

et al.

Asian Journal of Pharmaceutical Sciences, Journal Year: 2022, Volume and Issue: 17(5), P. 751 - 766

Published: Aug. 1, 2022

Ferroptosis is a novel form of programmed cell death impelled by iron-dependent lipid peroxidation, which may be potential strategy for cancer therapy. Here we demonstrated the first time that Resveratrol (RSV), traditional Chinese medicine (TCM) chemical monomer, could effectually inhibit growth colon cells through ROS-dependent ferroptosis pathway. Mechanistically, RSV evoked increase reactive oxygen species and peroxidation in colorectal cells, eventually lead to ferroptosis. Furthermore, promote downregulating expression channel protein solute carrier family 7 member 11 (SLC7A11) glutathione peroxidase 4 (GPX4). To improve delivery efficiency RSV, biomimetic nanocarrier was developed coating RSV-loaded poly(ε-caprolactone)-poly(ethylene glycol) (PCL-PEG) nanoparticles with erythrocyte membrane (RSV-NPs@RBCm). The RSV-NPs@RBCm provide possibility escape macrophage phagocytosis have long circulation effect. In addition, when coupled tumor-penetrating peptide iRGD, trigger enhanced tissue penetration tumor-specifically, into tumors would significantly improved results from vivo study an excellent treatment efficacy CRC. Altogether, our highlighted therapeutic as ferroptosis-inducing anticancer agent loaded nanoplatform, it might pave way application nanosystems treatment.

Language: Английский

Citations

96

Efficacy evaluation, active ingredients, and multitarget exploration of herbal medicine DOI
Junling Ren,

Le Yang,

Shi Qiu

et al.

Trends in Endocrinology and Metabolism, Journal Year: 2023, Volume and Issue: 34(3), P. 146 - 157

Published: Jan. 28, 2023

Language: Английский

Citations

54

Berberine is a suppressor of Hedgehog signaling cascade in colorectal cancer DOI
Qiang Sun, Tao Qiu,

Tianqi Ming

et al.

Phytomedicine, Journal Year: 2023, Volume and Issue: 114, P. 154792 - 154792

Published: March 30, 2023

Language: Английский

Citations

48

Xianlian Jiedu Decoction alleviates colorectal cancer by regulating metabolic profiles, intestinal microbiota and metabolites DOI
Ke Cai, Xinyue Cao, Fan Chen

et al.

Phytomedicine, Journal Year: 2024, Volume and Issue: 128, P. 155385 - 155385

Published: Jan. 27, 2024

Language: Английский

Citations

21

Shikonin, a naphthalene ingredient: Therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches DOI
Qiang Sun, Ting Gong,

Maolun Liu

et al.

Phytomedicine, Journal Year: 2021, Volume and Issue: 94, P. 153805 - 153805

Published: Oct. 25, 2021

Language: Английский

Citations

102

Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches DOI
Mingyi Shi,

Zixian Chen,

Hui Gong

et al.

Phytotherapy Research, Journal Year: 2023, Volume and Issue: 38(2), P. 880 - 911

Published: Dec. 13, 2023

Abstract Current pharmaceutical research is energetically excavating the pharmacotherapeutic role of herb‐derived ingredients in multiple malignancies’ targeting. Luteolin one major phytochemical components that exist various traditional Chinese medicine or medical herbs. Mounting evidence reveals this phytoconstituent endows prominent therapeutic actions on diverse malignancies, with underlying mechanisms, combined medication strategy, and pharmacokinetics elusive. Additionally, clinical trial investigation luteolin remain to be systematically delineated. The present review aimed comprehensively summarize updated information regard anticancer mechanism, strategies, pharmacokinetics, trials, researches luteolin. survey corroborates executes effects mainly by dampening proliferation invasion, spurring apoptosis, intercepting cell cycle, regulating autophagy immune, inhibiting inflammatory response, inducing ferroptosis, pyroptosis, as well epigenetic modification, so on. can applied combination numerous anticarcinogens natural synergistically enhance efficacy malignancies while reducing adverse reactions. For has an unfavorable oral bioavailability, it persists plasma glucuronides sulfate‐conjugates after being metabolized, regarded potent inhibitors OATP1B1 OATP2B1, which may messed pharmacokinetic interactions miscellaneous bioactive substances vivo. Besides, innovation leading‐edge drug delivery systems such host–guest complexes, nanoparticles, liposomes, nanoemulsion, microspheres, hydrogels are beneficial exploitation luteolin‐based products. Moreover, some registered trials carried out, yet should continuously promoted.

Language: Английский

Citations

25

The effective combination therapies with irinotecan for colorectal cancer DOI Creative Commons
Yun Chai, Jingli Liu, Shuo Zhang

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: Feb. 5, 2024

Colorectal cancer is the third most common type of worldwide and has become one major human disease burdens. In clinical practice, treatment colorectal been closely related to use irinotecan. Irinotecan combines with many other anticancer drugs a broader range drug combinations. Combination therapy important means improving anti-tumor efficacy overcoming resistance. Reasonable combination can lead better patient options, inappropriate will increase risk. For therapeutic field, significance improve efficacy, reduce adverse effects, ease treatment. Therefore, we explored advantages its based on mechanism or metabolism reviewed rationale basis limitations in conducting exploratory trials irinotecan therapy, including results potentiation cytotoxic drugs, targeted agents, herbal medicine. We hope that these evoke more efforts conduct laboratory for further studies evaluations, as well possibility in-depth development future trials.

Language: Английский

Citations

13

Chinese herbal medicine for the treatment of intestinal cancer: preclinical studies and potential clinical applications DOI Creative Commons

Juan Zhang,

Yulin Wu,

Yuanyang Tian

et al.

Molecular Cancer, Journal Year: 2024, Volume and Issue: 23(1)

Published: Oct. 1, 2024

Language: Английский

Citations

11

Treatment of colorectal cancer by traditional Chinese medicine: prevention and treatment mechanisms DOI Creative Commons
Jiaxin Sun, Ying Wei, Jia Wang

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: May 9, 2024

Colorectal cancer (CRC) is a significant global health burden, with high morbidity and mortality rates. It often diagnosed at middle to advanced stage, affecting approximately 35% of patients the time diagnosis. Currently, chemotherapy has been used improve patient prognosis increase overall survival. However, can also have cytotoxic effects lead adverse reactions, such as inhibiting bone marrow hematopoiesis, causing digestive dysfunction, hand-foot syndrome, even life-threatening conditions. In response these effects, researchers proposed using Traditional Chinese Medicine (TCM) an option treat cancer. TCM research focuses on prescriptions, herbs, components, which form essential components current in medicine. The study implementation prescriptions herbs demonstrate its distinctive holistic approach therapy, characterized by applying multi-component multi-target treatment. TMC advantages developing new drugs they consist single ingredients, require smaller medication dosages, precise measure pharmacodynamic clear mechanism action compared herbs. further still needed determine whether fully substitute therapeutic efficacy prescriptions. This paper presents comprehensive analysis advancements made components. findings this serve theoretical basis for who are interested exploring potential treatment colorectal

Language: Английский

Citations

9